Oliver Frank

Oliver Frank

Auto-generated profile, based on publicly available information

Oliver Frank

School of Medicine, College of Health Adelaide University Adelaide Australia

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2012 in European Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
KRKarin Ried
Karin Ried
OFO R Frank
O R Frank
NSN P Stocks
N P Stocks
Hypertension affects about 30% of adults worldwide. Garlic has blood pressure-lowering properties and the mechanism of action is biologically plausible. Our trial assessed the effect, dose–response, tolerability and acceptability of different doses of aged garlic extract as an adjunct treatment to existing antihypertensive medication in patients with uncontrolled hypertension. A total of 79 general practice patients with uncontrolled systolic hypertension participated in a double-blind randomised placebo-controlled dose–response trial of 12 weeks. Participants were allocated to one of three garlic groups with either of one, two or four capsules daily of aged garlic extract (240/480/960 mg containing 0.6/1.2/2.4 mg of S-allylcysteine) or placebo. Blood pressure was assessed at 4, 8 and 12 weeks and compared with baseline using a mixed-model approach. Tolerability was monitored throughout the trial and acceptability was assessed at 12 weeks by questionnaire. Mean systolic blood pressure was significantly reduced by 11.8±5.4 mm Hg in the garlic-2-capsule group over 12 weeks compared with placebo (P=0.006), and reached borderline significant reduction in the garlic-4-capsule group at 8 weeks (−7.4±4.1 mm Hg, P=0.07). Changes in systolic blood pressure in the garlic-1-capsule group and diastolic blood pressure were not significantly different to placebo. Tolerability, compliance and acceptability were high in all garlic groups (93%) and highest in the groups taking one or two capsules daily. Our trial suggests aged garlic extract to be an effective and tolerable treatment in uncontrolled hypertension, and may be considered as a safe adjunct treatment to conventional antihypertensive therapy.

16 June 2008 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
KRKarin Ried
Karin Ried
OFOliver R Frank
Oliver R Frank
NSNigel P Stocks
Nigel P Stocks
PFPeter Fakler
Peter Fakler
TSThomas Sullivan
Thomas Sullivan
Non-pharmacological treatment options for hypertension have the potential to reduce the risk of cardiovascular disease at a population level. Animal studies have suggested that garlic reduces blood pressure, but primary studies in humans and non-systematic reviews have reported mixed results. With interest in complementary medicine for hypertension increasing, it is timely to update a systematic review and meta-analysis from 1994 of studies investigating the effect of garlic preparations on blood pressure.


23 December 2014 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
JYJoanne P. Young
Joanne P. Young
AWAung Win
Aung Win
CRChristophe Rosty
Christophe Rosty
IFIngrid Flight
Ingrid Flight
DRDavid Roder
David Roder
TPTimothy J. Price
Timothy J. Price

28 June 2010 in BMC Medicine
Verified
Journal Article
Open access
PDF file
KRKarin Ried
Karin Ried
TSThomas Sullivan
Thomas Sullivan
PFPeter Fakler
Peter Fakler
OFOliver R Frank
Oliver R Frank
NSNigel P Stocks
Nigel P Stocks
Dark chocolate and flavanol-rich cocoa products have attracted interest as an alternative treatment option for hypertension, a known risk factor for cardiovascular disease. Previous meta-analyses concluded that cocoa-rich foods may reduce blood pressure. Recently, several additional trials have been conducted with conflicting results. Our study summarises current evidence on the effect of flavanol-rich cocoa products on blood pressure in hypertensive and normotensive individuals.

13 June 2015 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Open access
PDF file
KWK. Westaway
K. Westaway
OFO. Frank
O. Frank
AHA. Husband
A. Husband
AMA. McClure
A. McClure
RSR. Shute
R. Shute
DRDebra Rowett
Debra Rowett
What is Known and objective Hot days are increasingly common and are often associated with increased morbidity and mortality, especially in the elderly. Most heat‐related illness and heat‐related deaths are preventable. Comment Medicines may accentuate the risk of dehydration and heat‐related illness, especially in elderly people taking multiple medicines, through the following mechanisms: diuresis and electrolyte imbalance, sedation and cognitive impairment, changed thermoregulation, reduced thirst recognition, reduced sweat production, and hypotension and reduced cardiac output. What is new and conclusion Commonly used medicines that may significantly increase the risk include diuretics, especially when combined with an angiotensin converting enzyme (ACE) inhibitor or an angiotensin II receptor blocker (ARB), anticholinergics and psychotropics. Initiation of individualized preventive measures prior to the start of the hot weather season, which includes a review of the patient and their medicines to identify thermoregulatory issues, may reduce the risk of heat‐related illness or death.